Cambridge Investment Research Advisors’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $82K | Buy |
|
|||||
|
2025
Q2 | $36K | Sell |
|
|||||
|
2025
Q1 | $42K | Buy |
|
|||||
|
2024
Q4 | $66K | Buy |
|
|||||
|
2024
Q3 | $16K | Sell |
|
|||||
|
2024
Q2 | $34K | Sell |
|
|||||
|
2024
Q1 | $59K | Sell |
|
|||||
|
2023
Q4 | $683K | Buy |
|
|||||
|
2023
Q3 | $86K | Buy |
|
|||||
|
2023
Q2 | $93K | Hold |
|
|||||
|
2023
Q1 | $148K | Buy |
|
|||||
|
2022
Q4 | $134K | Buy |
|
|||||
|
2022
Q3 | $146K | Sell |
|
|||||
|
2022
Q2 | $113K | Hold |
|
|||||
|
2022
Q1 | $201K | Hold |
|
|||||
|
2021
Q4 | $249K | Sell |
|
|||||
|
2021
Q3 | $279K | Sell |
|
|||||
|
2021
Q2 | $243K | Buy |
|